US2013209417A1PendingUtilityA1
Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
Est. expiryApr 12, 2025(expired)· nominal 20-yr term from priority
A61P 9/00A61P 43/00A61P 9/04C12N 5/163C12N 5/068C12N 2533/56C12Q 1/42C07K 16/40C12N 5/0081C12N 5/0663A61P 19/02G01N 33/68G01N 2333/916A61P 19/00A61K 2035/124A61P 19/08C07K 2317/76G01N 33/577
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the use of tissue non-specific alkaline phosphatase (TNAP) as a marker for identifying and/or isolating adult multipotential cells. The present invention also relates to cell populations enriched by methods of the present invention and therapeutic uses of these cells.
Claims
exact text as granted — not AI-modified1 . Use of TNAP as a marker for the identification and/or enrichment of adult multipotential cells.
2 . A method of enriching for adult multipotential cells, the method comprising preparing a cell sample from a tissue source and enriching for adult multipotential cells that express the TNAP marker.
3 . A method according to claim 2 which comprises:
contacting the cell sample with a TNAP binding agent under conditions that allows binding of TNAP to the TNAP binding agent; and
separating cells bound to the TNAP binding agent.
4 - 5 . (canceled)
6 . A method according to claim 3 wherein the TNAP binding agent binds specifically to the BAP isoform of TNAP.
7 . (canceled)
8 . A method according to claim 6 wherein the anti-TNAP antibody is an antibody that binds to the same epitope as the STRO-3 antibody produced by the hybridoma cell line deposited with ATCC on 19 Dec. 2005 under the provisions of the Budapest Treaty under deposit accession number PTA-7282.
9 . (canceled)
10 . A method according to claim 8 wherein the anti-TNAP antibody is the STRO-3 antibody produced by the hybridoma cell line deposited with ATCC on 19 Dec. 2005 under the provisions of the Budapest Treaty under deposit accession number PTA-7282.
11 - 16 . (canceled)
17 . A method according to claim 2 for identifying the presence of an adult multipotential cell in a cell sample, the method comprising identifying cells in the sample that express the TNAP marker.
18 . An enriched population of adult multipotential cells obtained by a method according to claim 1 .
19 . An enriched population of TNAP+ adult multipotential cells.
20 . An expanded cell population obtained by culturing an enriched population of adult multipotential cells according to claim 18 .
21 . (canceled)
22 . A method of generating a tissue specific committed cell population, the method comprising
culturing a population of adult multipotential cells according to claim 18 in the presence of one or more stimulatory factors; and subjecting said cultured population to conditions biasing differentiation of the adult multipotential cells to a specific tissue type.
23 - 24 . (canceled)
25 . A composition comprising a population of enriched adult multipotential cells according to claim 18 .
26 - 28 . (canceled)
29 . A method for generating or repairing tissue in a subject, the method comprising administering to the subject an enriched or expanded cell population according to claim 18 .
30 . A method for generating or repairing tissue in a subject, the method comprising administering to the subject a composition according to claim 25 .
31 . A method according to claim 29 wherein the tissue is bone, cardiac, or cartilage tissue.
32 - 37 . (canceled)
38 . An isolated cell which has been obtained by a method according to claim 1 , or a progeny cell thereof, wherein the cell is genetically modified.
39 - 45 . (canceled)Join the waitlist — get patent alerts
Track US2013209417A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.